Drug class
Serotonin-3 Receptor Antagonist
Mechanism of action
Serotonin 3 Receptor Antagonists [MoA]
General use cases
- nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration
- nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days
- acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
